Literature DB >> 2037011

Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain.

F Nadimi1, J Moreno, F Momburg, A Heuser, S Fuchs, L Adorini, G J Hämmerling.   

Abstract

The influence of the class II-associated invariant chain (Ii) on the presentation of the protein antigens hen egg-white lysozyme (HEL) and ribonuclease A (RNase) was investigated. For this purpose the Ii- rat-2 fibroblasts were transfected with I-Ak genes with or without Ii. Transfectants expressing Ii were superior in the presentation of the complete HEL protein to a panel of I-Ak-restricted T hybridomas characterized by distinct specificities for different HEL peptides and by different sensitivities to antigen concentration. There appeared to be a correlation between the antigen-presenting capacity and the amount of Ii, in that transfectants expressing large amounts of Ii were the best antigen presentors. The presentation of synthetic HEL peptides was not influenced by Ii. In contrast to the findings with HEL, the presentation of RNase by the same set of transfectants was clearly independent of Ii. Both antigens, HEL and RNase, required processing in the chloroquine-sensitive compartment. However, only the presentation of HEL but not of RNase could be efficiently blocked by brefeldin A. These data confirm that presentation of HEL depends on de novo synthesized class II molecules, whereas the presentation of RNase seems to be predominantly mediated by a pool of pre-existing class II molecules whose interaction with endocytosed antigen does not depend on Ii. These results suggest different mechanisms for the presentation of HEL and RNase and they raise the possibility that different antigens intersect the class II pathway at distinct intracellular locations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2037011     DOI: 10.1002/eji.1830210524

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.

Authors:  K Frauwirth; N Shastri
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

Review 2.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

3.  Distinct antigen MHC class II complexes generated by separate processing pathways.

Authors:  R Lindner; E R Unanue
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

4.  Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes.

Authors:  S Tourne; T Miyazaki; P Wolf; H Ploegh; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

5.  Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity.

Authors:  T D Armstrong; V K Clements; B K Martin; J P Ting; S Ostrand-Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 6.  Endosomal localization of MHC class II-invariant chain complexes.

Authors:  J Miller
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

7.  Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41.

Authors:  B Fineschi; L S Arneson; M F Naujokas; J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum.

Authors:  R Busch; I Cloutier; R P Sékaly; G J Hämmerling
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

9.  The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide.

Authors:  G Gradehandt; N Kleber; F Mattner; S Milbradt; E Rüde
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

10.  Functional HLA-DM on the surface of B cells and immature dendritic cells.

Authors:  S O Arndt; A B Vogt; S Markovic-Plese; R Martin; G Moldenhauer; A Wölpl; Y Sun; D Schadendorf; G J Hämmerling; H Kropshofer
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.